Crossref
Repurposing phenytoin as an anti-aggression drug: clinical evidence
Neurological Disorders and Therapeutics · 2017
DOI: 10.15761/ndt.1000118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Disorders and Therapeutics, 2017. Verfasst von Jan M. Keppel Hesselink.
Themen: Gewalt gegen Pflegekräfte
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hesselink, J. M. K. (2017). Repurposing phenytoin as an anti-aggression drug: clinical evidence. Neurological Disorders and Therapeutics. https://doi.org/10.15761/ndt.1000118
Vancouver
Hesselink JMK. Repurposing phenytoin as an anti-aggression drug: clinical evidence. Neurological Disorders and Therapeutics. 2017. doi:10.15761/ndt.1000118
BibTeX
@article{Hesselink2017,
author = {Hesselink, Jan M. Keppel},
title = {Repurposing phenytoin as an anti-aggression drug: clinical evidence},
journal = {Neurological Disorders and Therapeutics},
year = {2017},
doi = {10.15761/ndt.1000118}
}
EUVIMED